Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay

Molecular Endocrinology

Volumn 11, Issue 6, 1997, Pages 779-791

  Krey, Grigorios ^a   Braissant, Olivier ^a   L'Horset, Fabienne ^b   Kalkhoven, Eric ^b   Perroud, Mai ^a   Parker, Malcolm G ^b   Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ARACHIDONIC ACID DERIVATIVE; BEZAFIBRATE; CIPROFIBRATE; FATTY ACID; ICOSANOID; ICOSAPENTAENOIC ACID; LEUKOTRIENE B4; LINOLEIC ACID; PEROXISOME PROLIFERATOR; PIRINIXIC ACID; PROSTAGLANDIN J2;

ARTICLE; GENETIC TRANSCRIPTION; HOMEOSTASIS; LIGAND BINDING; LIPID METABOLISM; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

CARLA; XENOPUS LAEVIS;

EID: 0030985318     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.6.0007     Document Type: Article

References (34)

1. Desvergne B, Wahli W 1995 PPAR: a key nuclear factor in nutrient/gene interactions? In: Bauerle PA (ed) Inducible Gene Expression. Birkhäuser, Boston, vol 1:142-176
2. Wahli W, Braissant O, Desvergne B 1995 Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. . . Chem Biol 2:261-266
3. Lemberger T, Desvergne B, Wahli W 1996 PPARs: a nuclear receptor signaling pathway in lipid metabolism. Annu Rev Cell Dev Biol 12:335-363
4. Issemann I, Green S 1990 Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferator. Nature 347:645-650
5. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W 1992 Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68:879-887
6. Göttlicher M, Widmark E, Li Q, Gustafsson J-Å 1992 Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 89:4653-4657
7. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W 1993 Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid × receptor heterodimers. Proc Natl Acad Sci USA 90:2160-2164
8. Krey G, Keller H, Mahfoudi A, Wahli W 1995 PPARs: nuclear receptors controlling peroxisomal fatty acid β-oxidation. In: Wanders RJA, Schutgens RBH, Tabak HF (eds) Function and Biogenesis of Peroxisomes in Relation to Human Disease. North-Holland Press, Amsterdam, pp 167-200
9. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA 1995 An antidiabetic thiazolidinedione is a high affinity ligand for the nuclear receptor PPARγ. J Biol Chem 270:12953-12956
10. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM 1995 A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813-819
11. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM 1995 15-deoxy-delta(12, 14)-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR-gamma. Cell 83:803-812
12. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W 1996 The PPARα-leukotriene B4 pathway to inflammation control. Nature 384:39-43
13. Cavaillès V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG 1995 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751
14. Le Douarin B, Zechel C, Gamier J-M, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R 1995 The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033
15. Vom Baur E, Zechel C, Heery D, Heine MJS, Gamier JM, Vivat V, Le Douarin B, Gronemeyer H, Chambon P, Losson R 1996 Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 15:110-124
16. Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675
17. Oñate SA, Tsai SY, Tsai M-Y, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
18. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman RA, Rose, DW, Glass CK, Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414
19. Krey G, Keller H, Mahfoudi A, Medin J, Ozato K, Dreyer C, Wahli W 1993 Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid × receptor and activation by fatty acids. J Steroid Biochem Mol Biol 47:65-73
20. Yu K, Bayona W, Kallen CB, Harding HP, Ravera CP, Mcmahon G, Brown M, Lazar MA 1995 Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 270:23975-23983
21. Hertz R, Berman I, Keppler D, Bar-Tana J 1996 Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators activated receptor (PPAR). Eur J Biochem 235:242-247
22. Murray RK, Granner DK, Mayes PA, Rodwell VW 1988 Harper's Biochemistry, ed 21. Appleton and Lange, Norwalk, CT, p 226
23. Fitzpatrick FA, Murphy RC 1989 Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. Pharmacol Rev 40:229-241
24. Spector AA, Gordon JA, Moore SA 1988 Hydroxyeicosatetraenoic acids (HETEs). Prog Lipid Res 27:271-323
25. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W 1996 Differential expression of peroxisome proliferator-activated receptors (PPARS): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137:354-366
26. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA 1992 Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 6:1634-1641
27. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM 1994 Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91:7355-7359
28. Amri E-Z, Bonino F, Ailhaud G, Abumrad NA, Grimaldi PA 1995 Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 270:2367-2371
29. Nolan J, Ludvik B, Beerdsen P, Joyce M, Olefsky J 1994 Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193
30. Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, Spiegelman BM 1996 Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev 10:974-984
31. Spiegelman BM, Flier JS 1996 Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389
32. Sher T, Yi HF, McBride OW, Gonzalez FJ 1993 cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32:5598-5604
33. Eibrecht A, Chen YL, Cullinan CA, Hayes N, Leibowitz MD, Moller DE Berger J 1996 Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gasmma-1 and gamma-2. Biochem Biophys Res Commun 224:431-437
34. MacGregor GR, Caskey CT 1989 Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res 17:2365